NCT00118612 - Different Doses of Tyrosine Adsorbed Tree Pollen Allergoid With Monophosphoryl Lipid A (MPL) in Patients Sensitized to Tree Pollen | Biotech Hunter

Enrollment

Participants

Timeline

Start Date

July 7, 2005

Primary Completion Date

September 15, 2005

Study Completion Date

September 15, 2005

Conditions

Type I Hypersensitivity

Interventions

BIOLOGICAL

Tree MATA MPL - Therapeutic Regimen

600, 1600, 4000, 4000 SU/0.5 mL

BIOLOGICAL

Tree MATA MPL - Intermediate dose

300, 600, 1600, 1600 SU/0.5 mL

BIOLOGICAL

Tree MATA MPL - Low dose

300, 300, 300, 300 SU/0.5 mL

BIOLOGICAL

Placebo

L-tyrosine 2% w/v , 4 injections

Trial Locations (1)

Allied Research International Inc., Mississauga